CentralPoint
Eliem Therapeutics executive sells over $9,000 in company stock, a move that has sent ripples through the pharmaceutical industry and sparked speculation among investors. The executive’s decision to offload a significant portion of their holdings has raised eyebrows, prompting questions about the company’s future prospects and the motives behind the …
Read More »Eliem Therapeutics Executive Sells Over $9,000 in Company Stock
